Back to all news
OpenEvidence Hits $12B Valuation as Clinical AI Adoption Surges, AI Chatbots Named Top 2026 Healthcare Hazard
OpenEvidence becomes the leading AI platform among U.S. physicians, securing a $12B valuation amid rising concerns about AI chatbot misuse in healthcare.
Key Details
- 1OpenEvidence raises $250M, now valued at $12B, doubling its valuation since October; exceeds $100M annual revenue.
- 2The platform's flagship product supported 18M U.S. physician consultations in December, up from 3M/month a year prior.
- 3Over 40% of U.S. doctors now use OpenEvidence, with 100M+ patients treated via its tools in 2025.
- 4Amazon launches an AI health assistant within its One Medical app, continuing Big Tech's push into clinical AI ecosystems.
- 5ECRI cites 'misuse of AI chatbots' as the #1 health tech hazard for 2026, highlighting serious risks in clinical settings.
Why It Matters
These developments exemplify both the rapid integration and scaling of clinical AI platforms and the urgent need for oversight to mitigate risks—especially as AI becomes more deeply embedded in healthcare. For radiology and imaging AI, these trends spotlight key adoption metrics, the growing ecosystem, and the importance of responsible deployment.
Source
HealthExec
Related News
•Radiology Business
Aidoc Raises $150M to Expand Imaging AI Portfolio and Global Reach
Aidoc secures $150M in Series E funding led by Goldman Sachs to accelerate expansion of its clinical AI platform.
•AuntMinnie
AI-Driven Mammogram Analysis Boosts Cardiovascular Risk Prediction in Women
AI quantification of breast arterial calcifications (BACs) on mammograms enhances prediction of cardiovascular events beyond traditional risk models.
•HealthExec
UT Austin to Launch $1B+ AI-Driven Medical Center With Major Gift
UT Austin receives $750 million from Michael and Susan Dell toward a $1 billion+ AI-native medical center opening in 2030.